Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of starting cART on coagulation, inflammation, and cardiovascular markers in adults with HIV-1
NL-OMON34363Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2010
- Countries
- 1
01
Overview
Open-label, single-arm trial in Human immunodeficiency virus infection type 1, sponsored by University Medical Center Groningen. Primary endpoint: Change in thrombophilic factor levels from baseline during 1 year of cART. Started Aug 2010; status: active, not recruiting.
02
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON34363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34363.